Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
58
58 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- KarX-ECBMS-986519, Xanomeline Enteric-coatedPhase 39 trials
Bristol Myers Squibb · Alzheimer Disease, Alzheimer's Disease, Irritability Associated With Autism Spectrum Disorder
- ObicetrapibPhase 37 trials
NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption
- ITI-1284JNJ-99245354Phase 36 trials
Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders
- NPI-001N-Acetylcysteine AmidePhase 35 trials
Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease
- ACP-204Phase 34 trials
ACADIA Pharmaceuticals Inc. · Alzheimer's Disease Psychosis, Lewy Body Dementia Psychosis
- TrontinemabRO7126209, RG6102Phase 34 trials
Roche (Genentech) · Alzheimers Disease, Alzheimer's Disease
- AXS-05dextromethorphan-bupropionPhase 33 trials
Axsome Therapeutics, Inc. · Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Smoking Cessation
- buntanetapposiphenPhase 33 trials
Annovis Bio Inc. · Early Alzheimers Disease, Alzheimer's Dementia (AD), Parkinson's Disease (PD)
- MasitinibAB1010Phase 33 trials
AB Science · Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Alzheimer Disease
- SPG302TazbentetolPhase 33 trials
Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis
- TertomotideGV1001Phase 33 trials
GemVax & Kael · Moderate to Severe Alzheimer's Disease, Mild to Moderate Alzheimer's Disease, Progressive Supranuclear Palsy
- [18F]-APN-1607Phase 32 trials
JYAMS PET Research & Development Limited · Alzheimer's Disease, Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia
- Combined metabolic activatorsPhase 32 trials
ScandiBio Therapeutics AB · Alzheimer Disease, Gout Disease
- DMB-IINN: Latrepirdine, DimebonPhase 32 trials
Bigespas LTD · Alzheimer Type Dementia, Alzheimer Disease, Dementia of Alzheimer Type
- SemagludtidePhase 32 trials
Lumos Pharma · Obesity & Overweight, Early Alzheimer's Disease
- AR1001Phase 31 trial
AriBio Co., Ltd. · Alzheimer Disease
- EXV-801deramciclanePhase 31 trial
Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia
- EXV-802Phase 31 trial
Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia
- Huperzine A Controlled-ReleasePhase 31 trial
Wanbangde Pharmaceutical Group Co., LTD · Alzheimer Dementia
- MLC 901Phase 31 trial
Moleac Pte Ltd. · Alzheimer's Disease Dementia
- RemternetugLY3372993Phase 31 trial
Eli Lilly · Alzheimer's Disease
- SUVN-502MasupirdinePhase 31 trial
Suven Life Sciences Limited · Agitation, Alzheimer's Type Dementia
- XTR006[18F]MK 6240, FlorquinitauPhase 31 trial
Sinotau Pharmaceutical Group · Alzheimer Disease, Neurofibrillary Tangle
- ML-007C-MAPhase 24 trials
MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia
- [18F]F-AraGPET tracer, 2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguaninePhase 22 trials
CellSight Technologies, Inc. · Alzheimer Disease (AD), Covid19, SARS-CoV Infection
- AMDX-2011PPhase 22 trials
Amydis Inc. · Cerebral Amyloid Angiopathy, Alzheimer Disease
- BMS-986368CC-97489Phase 22 trials
Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity
- CT1812Study Drug ActivePhase 22 trials
Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies
- KDS2010Phase 22 trials
NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients
- mivelsiranALN-APPPhase 22 trials
Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- ONO-2020Phase 22 trials
Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease
- RO7568282Phase 22 trials
Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease
- SNK01Phase 22 trials
NKGen Biotech, Inc. · Alzheimer Disease, Moderate Alzheimer Disease
- VHB937Phase 22 trials
Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease
- ABBV-1758Phase 21 trial
AbbVie · Alzheimer's Disease
- ABBV-916Phase 21 trial
AbbVie · Alzheimer's Disease (AD)
- ALZN002autologous DCs pulsed with E22W mutant peptidePhase 21 trial
Alzamend Neuro, Inc. · Alzheimer Disease
- BEY2153Phase 21 trial
BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease
- BMS-986446Phase 21 trial
Bristol Myers Squibb · Alzheimer Disease, Early Onset
- DiranersenISIS 814907, BIIB080Phase 21 trial
Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
- E2814Phase 21 trial
Eisai · Alzheimer's Disease
- EI-1071Phase 21 trial
Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease
- EX039Phase 21 trial
Excelsior · Alzheimer Disease
- GSK4527226Phase 21 trial
GSK · Alzheimer's Disease
- HT-4253Phase 21 trial
Halia Therapeutics, Inc. · Alzheimers Disease
- IVL3003Phase 21 trial
Inventage Lab., Inc. · Alzheimer Disease
- JNJ-64042056Phase 21 trial
Johnson & Johnson (Janssen) · Alzheimer Disease
- LHP588Phase 21 trial
Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
- MK-2214Phase 21 trial
Merck & Co. · Early Alzheimer's Disease
- NBI-1117567Phase 21 trial
Neurocrine Biosciences · Alzheimer's Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.